rs104893764
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000306.4(POU1F1):c.688G>A(p.Glu230Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,613,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000096 ( 0 hom. )
Consequence
POU1F1
NM_000306.4 missense
NM_000306.4 missense
Scores
12
5
1
Clinical Significance
Conservation
PhyloP100: 7.54
Genes affected
POU1F1 (HGNC:9210): (POU class 1 homeobox 1) This gene encodes a member of the POU family of transcription factors that regulate mammalian development. The protein regulates expression of several genes involved in pituitary development and hormone expression. Mutations in this genes result in combined pituitary hormone deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.976
PP5
Variant 3-87260082-C-T is Pathogenic according to our data. Variant chr3-87260082-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 13613.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-87260082-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POU1F1 | NM_000306.4 | c.688G>A | p.Glu230Lys | missense_variant | 6/6 | ENST00000350375.7 | NP_000297.1 | |
POU1F1 | NM_001122757.3 | c.766G>A | p.Glu256Lys | missense_variant | 6/6 | NP_001116229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POU1F1 | ENST00000350375.7 | c.688G>A | p.Glu230Lys | missense_variant | 6/6 | 1 | NM_000306.4 | ENSP00000263781 | P4 | |
POU1F1 | ENST00000560656.1 | c.462G>A | p.Trp154Ter | stop_gained | 4/4 | 5 | ENSP00000452610 | |||
POU1F1 | ENST00000344265.8 | c.766G>A | p.Glu256Lys | missense_variant | 6/6 | 5 | ENSP00000342931 | A1 | ||
POU1F1 | ENST00000561167.5 | c.463G>A | p.Glu155Lys | missense_variant | 5/5 | 5 | ENSP00000454072 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151970Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
151970
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250200Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135272
GnomAD3 exomes
AF:
AC:
6
AN:
250200
Hom.:
AF XY:
AC XY:
4
AN XY:
135272
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461646Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727114
GnomAD4 exome
AF:
AC:
14
AN:
1461646
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
727114
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151970Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74206
GnomAD4 genome
AF:
AC:
1
AN:
151970
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74206
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Pituitary hormone deficiency, combined, 1 Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 2005 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Department Of Genetics, Sultan Qaboos University Hospital, Sultan Qaboos University | Jun 30, 2022 | - - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 27, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies demonstrate a damaging effect on transcription activation (Liang et al., 1995; Turton et al., 2005); This variant is associated with the following publications: (PMID: 19837867, 36344539, 31702014, 34815942, 20852587, 15928241, 7592721, 11924936, 33742319) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 13, 2023 | Experimental studies have shown that this missense change affects POU1F1 function (PMID: 15928241). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 230 of the POU1F1 protein (p.Glu230Lys). This variant is present in population databases (rs104893764, gnomAD 0.005%). This missense change has been observed in individuals with autosomal recessive combined pituitary hormone deficiency (PMID: 11924936, 15928241). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13613). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on POU1F1 protein function. For these reasons, this variant has been classified as Pathogenic. - |
POU1F1-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 27, 2024 | The POU1F1 c.688G>A variant is predicted to result in the amino acid substitution p.Glu230Lys. This variant has been reported in the homozygous and compound heterozygous states in multiple patients with POU1F1 related pituitary hormone deficiency, and functional studies support its pathogenicity (Gat-Yablonski et al. 2002. PubMed ID: 11924936; Turton et al. 2005. PubMed ID: 15928241). This variant is reported in 0.0044% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;.;.
MutationTaster
Benign
A;A;A
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;.
Polyphen
D;D;.
Vest4
MutPred
Gain of MoRF binding (P = 0.004);.;.;
MVP
MPC
0.36
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at